Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

517 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Emphysema, airflow obstruction, and left ventricular filling.
Watz H, Waschki B, Magnussen H. Watz H, et al. Among authors: magnussen h. N Engl J Med. 2010 Apr 29;362(17):1638-9; author reply 1640-1. doi: 10.1056/NEJMc1002018. N Engl J Med. 2010. PMID: 20427814 No abstract available.
Withdrawal of inhaled glucocorticoids and exacerbations of COPD.
Magnussen H, Disse B, Rodriguez-Roisin R, Kirsten A, Watz H, Tetzlaff K, Towse L, Finnigan H, Dahl R, Decramer M, Chanez P, Wouters EF, Calverley PM; WISDOM Investigators. Magnussen H, et al. N Engl J Med. 2014 Oct 2;371(14):1285-94. doi: 10.1056/NEJMoa1407154. Epub 2014 Sep 8. N Engl J Med. 2014. PMID: 25196117 Free article. Clinical Trial.
Inhaled glucocorticoids and COPD exacerbations.
Magnussen H, Tetzlaff K, Calverley PM. Magnussen H, et al. N Engl J Med. 2015 Jan 1;372(1):93-4. doi: 10.1056/NEJMc1413308. N Engl J Med. 2015. PMID: 25551535 Free article. No abstract available.
Efficacy of a new once-daily long-acting inhaled beta2-agonist indacaterol versus twice-daily formoterol in COPD.
Dahl R, Chung KF, Buhl R, Magnussen H, Nonikov V, Jack D, Bleasdale P, Owen R, Higgins M, Kramer B; INVOLVE (INdacaterol: Value in COPD: Longer Term Validation of Efficacy and Safety) Study Investigators. Dahl R, et al. Among authors: magnussen h. Thorax. 2010 Jun;65(6):473-9. doi: 10.1136/thx.2009.125435. Thorax. 2010. PMID: 20522841 Clinical Trial.
517 results